GTR 97176800
Tenders Are Invited For Pharmaceutical Products-Openhouse Methods Various Drug Active Ingredients From 01.10.2025
ICB — International Competitive Bid
Closes Dec 31, 2027
Western Europe
Tender Information
GTR Reference
97176800
Tendering Authority
Subscribe to view
Tender No
336016-2025
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products-Openhouse Methods Various Drug Active Ingredients From 01.10.2025
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
31-12-2027
Work Detail
Pharmaceutical Products-Openhouse Methods Various Drug Active Ingredients From 01.10.2025. The Aok Rhineland/Hamburg Announces The Conclusion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With Any Final Option Within The Framework Of So-Called Openhouse Methods For Various Drug Active Substances With The Earliest Possible Start Of The Contract On October 1, 2025. The Concrete Drug Active Substances And The Respective, Earliest Possible Start Of Contract Can Be Found In The Current Pharmaceutical Active Ingredient List In The Project Space Of The Award Portal Dtvp In The Category Of Tender Documents. Under The Specification Of Uniform Contractual Conditions And Uniform Access Procedures, All Suitable And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Is Offered Or Accession To A Discount Contract In Accordance With Section 130A (8) Sgb V. Interested Pharmaceutical Companies Can Receive The Participation Documents In The Project Space Of The Award Portal Dtvp Under The Section Of Tender Documents. The Prerequisite For The Conclusion Of A Contract Is That The Interested Pharmaceutical Company Fully Filled Out The Requested Participation Documents And Signed The Following E-Mail Mailbox: [email protected]. This E-Mail Inbox Is Replaced By All Exchange Of Documents And Documents For The Implementation Of The Openhouse Procedure Between The Companies And The Middle Of Medicine Of The Aok Rhineland/Hamburg. A Contract Is Concluded With Every Pharmaceutical Company That Meets The Prerequisites For Participation. There Is No Exclusivity. The Accession Or Conclusion Of The Contract Can Take Place At Any Time And On The Same Conditions. Individual Contract Negotiations Are Not Managed. . The Earliest Start Of The Contract Is 01.10.2025. The Conclusion Or Access To A Discount Contract Is Possible At Any Time, I.E. After October 1St, 2025. The Contract Term Ends Uniformly On December 31, 2027, Regardless Of The Individual Start Of The Contract. The List With The Contractual Active Ingredients Is Changed At Irregular Intervals. In This Case, All Companies Verified In The Project Space In The Dtvp Award Portal Will Receive An Email With An Indication Of Which Active Ingredients Have Been Added And When The Respective, Earliest Possible Start Of Contract Is. If The Aok Rheinland/Hamburg Carry Out A Tender Of Exclusive Contracts In The Form Of An Eu-Wide, Open Procedure During The Contract Period, The Contracts Concluded In The Context Of This Publication Will Be Terminated In Accordance With The Contractual Regulations. The Present Publication Is Not The Allocation Of A Public Mandate Within The Meaning Of The Award Coordination Directive (2014/24/Ec) Or The Public Procurement Law. In Order To Ensure The Highest Level Of Transparency For The Intended Contract Conclusions, The Publication Is Published In The Supplement To The Official Journal Of The European Union. Published In The Absence Of A Corresponding One
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
66e6b880-0b60-484d-8566-42d93c388e77.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.